Structural insights accelerate the discovery of opioid alternatives

T Che, BL Roth - Annual review of biochemistry, 2021 - annualreviews.org
Opioids such as morphine and oxycodone are analgesics frequently prescribed for the
treatment of moderate or severe pain. Unfortunately, these medications are associated with …

Predicting new molecular targets for known drugs

MJ Keiser, V Setola, JJ Irwin, C Laggner, AI Abbas… - Nature, 2009 - nature.com
Although drugs are intended to be selective, at least some bind to several physiological
targets, explaining side effects and efficacy. Because many drug–target combinations exist …

Opioids and their receptors: Are we there yet?

GW Pasternak - Neuropharmacology, 2014 - Elsevier
Opioids have an important place in pharmacology. While their clinical use as analgesics is
fundamental in medicine, their use is constrained by their side-effects and abuse potential …

Structure-based design of bitopic ligands for the µ-opioid receptor

A Faouzi, H Wang, SA Zaidi, JF DiBerto, T Che, Q Qu… - Nature, 2023 - nature.com
Mu-opioid receptor (µOR) agonists such as fentanyl have long been used for pain
management, but are considered a major public health concern owing to their adverse side …

Grand challenges of computer-aided drug design: The road ahead

JL Medina-Franco - Frontiers in Drug Discovery, 2021 - frontiersin.org
Background Computer-aided drug discovery (CADD) has become an essential part of
several projects in different settings and research environments. CADD has largely …

GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR‐mediated side effects

T Klabunde, A Evers - ChemBioChem, 2005 - Wiley Online Library
G protein‐coupled receptors (GPCRs) form a large protein family that plays an important role
in many physiological and pathophysiological processes. However, the central role that the …

D4 dopamine receptor high-resolution structures enable the discovery of selective agonists

S Wang, D Wacker, A Levit, T Che, RM Betz… - Science, 2017 - science.org
Dopamine receptors are implicated in the pathogenesis and treatment of nearly every
neuropsychiatric disorder. Although thousands of drugs interact with these receptors, our …

Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors

AW Bannon, MW Decker, MW Holladay, P Curzon… - Science, 1998 - science.org
Development of analgesic agents for the treatment of severe pain requires the identification
of compounds that are devoid of opioid receptor liabilities. A potent (inhibition constant= 37 …

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist

A Manglik, AC Kruse, TS Kobilka, FS Thian… - Nature, 2012 - nature.com
Opium is one of the world's oldest drugs, and its derivatives morphine and codeine are
among the most used clinical drugs to relieve severe pain. These prototypical opioids …

Charting, navigating, and populating natural product chemical space for drug discovery

H Lachance, S Wetzel, K Kumar… - Journal of medicinal …, 2012 - ACS Publications
STRONGHOLDS FOR DRUG DISCOVERY Historically, natural products (NPs) have played
a key role in the development of chemotherapy, 1, 2 and to this very day numerous marketed …